Skip to main content
. 2024 Jul 26;20(20):1385–1392. doi: 10.1080/14796694.2024.2351352

Table 1.

Baseline characteristics, all evaluable patients.

  Total (N = 110) Sunitinib first-line (n = 53) Other first-line (n = 57) p-value
Male, n (%) 84 (76.4) 45 (84.9) 39 (68.4) 0.042
Mean (SD) age at RCC diagnosis, years 60.9 (9.6) 58.4 (9.3) 63.3 (9.3) 0.005
Mean (SD) age at treatment initiation, years 65.5 (9.9) 63.0 (9.6) 67.9 (9.6) 0.005

RCC: Renal cell carcinoma; SD: Standard deviation.